Kalaris Therapeutics Inc (KLRS) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Kalaris Therapeutics Inc

    NASDAQ: KLRS · Real-Time Price · USD
    6.64
    -0.45 (-6.35%)
    At close: Oct 03, 2025, 3:59 PM
    6.77
    1.96%
    After-hours: Oct 03, 2025, 04:22 PM EDT

    Kalaris Therapeutics Inc Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q1 2025 Q2 2024 Q1 2024 Q4 2023
    Period Ending Mar 31, 2025 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023
    Net Income
    		 -10.2M -5.65M -3.41M -3.47M
    Depreciation & Amortization
    		 n/a n/a n/a n/a
    Stock-Based Compensation
    		 374K 322K 31K 31K
    Other Working Capital
    		 1.41M 425K -841K -1.31M
    Other Non-Cash Items
    		 35K 1.53M 931K 105K
    Deferred Income Tax
    		 n/a n/a n/a n/a
    Change in Working Capital
    		 2.35M -172K -2.08M -801K
    Operating Cash Flow
    		 -7.44M -3.97M -4.52M -4.14M
    Capital Expenditures
    		 n/a n/a n/a n/a
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a
    Other Investing Acitivies
    		 n/a n/a n/a n/a
    Investing Cash Flow
    		 n/a n/a n/a n/a
    Debt Repayment
    		 7.5M 5M 4.99M n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 99.77M -17K -5K 117K
    Financial Cash Flow
    		 107.27M 4.98M 6.58M 6.86M
    Net Cash Flow
    		 99.83M 1.01M 2.06M 2.72M
    Free Cash Flow
    		 -7.44M -3.97M -4.52M -4.14M

    Add to Watchlist